Close Menu

Purdue University chemist David Nichols says he never intended for the compounds he invented to become harmful street drugs, reports the Associated Press's Seth Borenstein. Chemicals Nichols made as possible treatments to Parkinson's disease or depression, and which were roughly similar to ecstasy and LSD, have been exploited by black market labs as recreational drugs instead, Borenstein says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.